Asparlas 3,750 unit/5 ML vial 5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FMDY5
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,366
Award facts
- Contract value 100% obligated
- $20,365.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 3,750 units of Asparlas (5 mL vials) with a ceiling value of $20,365.58. This firm fixed-price delivery order, issued on November 24, 2025, will be performed in Park Ridge and is scheduled for completion by December 16, 2025. The award was made without a set-aside designation, demonstrating DMS Pharmaceutical Group's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group has been registered in the System for Award Management since July 2001 and maintains a comprehensive product portfolio spanning oncology treatments, biologics, vaccines, specialty pharmaceuticals, and medical consumables.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy. The underlying IDC, awarded on November 13, 2025, carries a $499.999 billion ceiling and extends through December 31, 2036, with a 30-month base period followed by three 30-month option periods. The PPV-G GEN V program authorizes the issuance of firm fixed-price delivery orders for pharmaceutical products and medical consumables to support the recurring medical supply needs of Department of Defense healthcare facilities worldwide, positioning DMS Pharmaceutical Group as a critical supplier within the federal military medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FMDY5?
SPE2DR26FMDY5 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 24, 2025.
How much is contract SPE2DR26FMDY5 worth?
The government has obligated $20,366 on SPE2DR26FMDY5.
Is contract SPE2DR26FMDY5 an order under another contract?
Yes. SPE2DR26FMDY5 is a delivery order under SPE2DR25D9114, an indefinite delivery contract.
Was contract SPE2DR26FMDY5 competed?
The extent of competition for SPE2DR26FMDY5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award